SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)

Market Cap	3.27B
Revenue (ttm)	1.29B
Net Income (ttm)	299.66M
Shares Out	44.59M
EPS (ttm)	6.70
PE Ratio	10.93
Forward PE	n/a
Dividend	5.30 (7.23%)
Ex-Dividend Date	Jul 21, 2025

Volume	9,388
Average Volume	94,977
Open	73.10
Previous Close	73.30
Day's Range	73.00 - 73.50
52-Week Range	72.60 - 110.00
Beta	-0.07
RSI	18.52
Earnings Date	Aug 6, 2025

About Paramount Global

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, antiulcerative, antihypertensive, α- blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anest...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1982
• Employees: 227
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1777

Financial Performance

In 2024, SYN-TECH Chem. & Pharm.'s revenue was 1.26 billion, an increase of 12.83% compared to the previous year's 1.11 billion. Earnings were 393.28 million, an increase of 56.68%.